These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8941212)

  • 1. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
    Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
    Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis.
    Hoehner JC; Hedborg F; Eriksson L; Sandstedt B; Grimelius L; Olsen L; Påhlman S
    Lab Invest; 1998 Jan; 78(1):29-45. PubMed ID: 9461120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas.
    Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
    Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas.
    Gestblom C; Hoehner JC; Hedborg F; Sandstedt B; Påhlman S
    Am J Pathol; 1997 Jan; 150(1):107-17. PubMed ID: 9006328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts.
    Cooper MJ; Hutchins GM; Cohen PS; Helman LJ; Mennie RJ; Israel MA
    Cell Growth Differ; 1990 Apr; 1(4):149-59. PubMed ID: 1982060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival.
    Cooper MJ; Steinberg SM; Chatten J; Evans AE; Israel MA
    J Clin Invest; 1992 Dec; 90(6):2402-8. PubMed ID: 1281833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.
    Nilsson H; Jögi A; Beckman S; Harris AL; Poellinger L; Påhlman S
    Exp Cell Res; 2005 Feb; 303(2):447-56. PubMed ID: 15652356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
    J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
    Combaret V; Coll JL; Favrot MC
    Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
    Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
    Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
    Matsumura T; Sugimoto T; Sawada T; Amagai T; Negoro S; Kemshead JT
    Cancer Res; 1987 Jun; 47(11):2924-30. PubMed ID: 3567910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
    Liu S; Tian Y; Chlenski A; Yang Q; Salwen HR; Cohn SL
    Cancer Lett; 2005 Oct; 228(1-2):125-31. PubMed ID: 15935552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
    Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation.
    Peterson S; Bogenmann E
    Oncogene; 2004 Jan; 23(1):213-25. PubMed ID: 14712226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.